Ugur O - Search Results

1

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

Ugur O, Kothari PJ, Finn RD, Zanzonico P, Ruan S, Guenther I, Maecke HR, Larson SM. Ugur O, et al. Nucl Med Biol. 2002 Feb;29(2):147-57. doi: 10.1016/s0969-8051(01)00290-6. Nucl Med Biol. 2002. PMID: 11823119

2

Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.

Ugur O, Kostakoglu L, Hui ET, Fisher DR, Garmestani K, Gansow OA, Cheung NK, Larson SM. Ugur O, et al. Nucl Med Biol. 1996 Jan;23(1):1-8. doi: 10.1016/0969-8051(95)02001-2. Nucl Med Biol. 1996. PMID: 9004907

3

Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model.

Ugur O, Scott AM, Kostakoglu L, Hui TE, Masterson ME, Febo R, Sgouros G, Rosa E, Mehta BM, Fisher DR, et al. Ugur O, et al. Nucl Med Biol. 1995 Jan;22(1):87-93. doi: 10.1016/0969-8051(94)e0066-r. Nucl Med Biol. 1995. PMID: 7735175

4

Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy.

Gedik GK, Uğur O, Atilla B, Pekmezci M, Yildirim M, Seven B, Varoğlu E. Gedik GK, et al. Among authors: ugur o. Ann Nucl Med. 2006 Apr;20(3):183-8. doi: 10.1007/BF03027428. Ann Nucl Med. 2006. PMID: 16715948 Clinical Trial.

5

Functional nuclear medicine imaging of medullary thyroid cancer.

Bozkurt MF, Uğur O, Banti E, Grassetto G, Rubello D. Bozkurt MF, et al. Among authors: ugur o. Nucl Med Commun. 2008 Nov;29(11):934-42. doi: 10.1097/MNM.0b013e32830f4af2. Nucl Med Commun. 2008. PMID: 18836370 Review.

6

Comparison of Tc-99m EC and Tc-99m DTPA captopril scintigraphy to diagnose renal artery stenosis.

Uğur O, Serdengeçti M, Karaçalioğlu O, Peksoy I, Cekirge S, Aslan N, Ergün EL, Duranay M, Yurdakul M, Caner B, Bayhan H. Uğur O, et al. Clin Nucl Med. 1999 Aug;24(8):553-60. doi: 10.1097/00003072-199908000-00002. Clin Nucl Med. 1999. PMID: 10439173

7

Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.

Arslan N, Ilgan S, Yuksel D, Serdengecti M, Bulakbasi N, Ugur O, Ozguven MA. Arslan N, et al. Among authors: ugur o. Clin Nucl Med. 2001 Aug;26(8):683-8. doi: 10.1097/00003072-200108000-00004. Clin Nucl Med. 2001. PMID: 11452174

8

Intra-Arterial Radionuclide Therapies for Liver Tumors.

Bozkurt MF, Salanci BV, Uğur Ö. Bozkurt MF, et al. Among authors: ugur o. Semin Nucl Med. 2016 Jul;46(4):324-39. doi: 10.1053/j.semnuclmed.2016.01.008. Semin Nucl Med. 2016. PMID: 27237442 Review.

9

Is corticosteroid coinjection necessary for radiosynoviorthesis of patients with hemophilia?

Gedik GK, Uğur O, Atilla B, Dündar S. Gedik GK, et al. Among authors: ugur o. Clin Nucl Med. 2004 Sep;29(9):538-41. doi: 10.1097/01.rlu.0000134978.24797.3c. Clin Nucl Med. 2004. PMID: 15311118 Clinical Trial.

10

Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.

Ugur O, Kostakğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel D, Aras T, Bayhan H, Bekdik C. Ugur O, et al. Eur J Nucl Med. 1996 Oct;23(10):1367-71. doi: 10.1007/BF01367593. Eur J Nucl Med. 1996. PMID: 8781142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters